Skip to main content
. 2018 Mar 13;11(3):575–584. doi: 10.1016/j.tranon.2018.02.003

Figure 5.

Figure 5

Immunohistochemical analyses of DDR1 in surgical specimens from patients with GC. (A) Representative images of immunohistochemical staining at the border between the normal mucosa (right) and carcinoma (left). (B, C) Representative immunohistochemical staining images of DDR1 in human GC tissue samples. Both intestinal-type (B) and diffuse-type (C) human GC tissues showed immunopositivity in cancer cell membranes and cytoplasms. (D) Kaplan-Meier survival curves showed that overall survival was significantly shorter in the DDR1-positive group than in the negative group (P < .001).